| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017NatCo...815743G |
| P6179 | Dimensions Publication ID | 1085906744 |
| P356 | DOI | 10.1038/NCOMMS15743 |
| P932 | PMC publication ID | 5467228 |
| P698 | PubMed publication ID | 28589934 |
| P50 | author | Carissa Embury-Hyatt | Q66680009 |
| Darwyn Kobasa | Q66680091 | ||
| Charlene Ranadheera | Q66680660 | ||
| David B. Weiner | Q67465894 | ||
| Guy Boivin | Q90829727 | ||
| Bryce M Warner | Q91839046 | ||
| Derek Stein | Q96101016 | ||
| Jocelyne Piret | Q111076715 | ||
| Mable W Hagan | Q114446450 | ||
| Kaylie N Tran | Q114446451 | ||
| Geoff Soule | Q114446452 | ||
| Alexander Bello | Q123019198 | ||
| Jonathan Audet | Q54006393 | ||
| Robbin Lindsay | Q55193623 | ||
| Marc-Antoine de La Vega | Q55455306 | ||
| Niranjan Y Sardesai | Q57551755 | ||
| Trina Racine | Q59146337 | ||
| Bryan D Griffin | Q65555413 | ||
| Gary P. Kobinger | Q66679700 | ||
| David Safronetz | Q32642588 | ||
| P2093 | author name string | Jennifer Scott | |
| J Joseph Kim | |||
| Stephanie A Booth | |||
| Joel N Maslow | |||
| Young K Park | |||
| Valerie Smid | |||
| Kar Muthumani | |||
| Anna Majer | |||
| Kathy L Frost | |||
| Xiao-Jian Yao | |||
| Leanne Scharikow | |||
| Stephanie Kucas | |||
| Christine De Graff | |||
| Gordon McTavish | |||
| P2860 | cites work | Probable non-vector-borne transmission of Zika virus, Colorado, USA | Q22240615 |
| Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007 | Q22241244 | ||
| Potential sexual transmission of Zika virus | Q22330722 | ||
| Zika Virus Associated with Microcephaly | Q22683189 | ||
| Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report | Q23005539 | ||
| Characterization of a Novel Murine Model to Study Zika Virus | Q23667364 | ||
| Male-to-Male Sexual Transmission of Zika Virus — Texas, January 2016 | Q24047379 | ||
| The Brazilian Zika virus strain causes birth defects in experimental models | Q24047993 | ||
| Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise | Q24050115 | ||
| Zika virus impairs growth in human neurospheres and brain organoids | Q24083091 | ||
| A Mouse Model of Zika Virus Pathogenesis | Q24261408 | ||
| Late sexual transmission of Zika virus related to persistence in the semen | Q24576009 | ||
| Structural basis of potent Zika–dengue virus antibody cross-neutralization | Q24740325 | ||
| Vaccine protection against Zika virus from Brazil | Q25165129 | ||
| Zika virus in semen of a patient returning from a non-epidemic area | Q26247138 | ||
| Long Lasting Persistence of Zika Virus in Semen | Q26248718 | ||
| Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys | Q26248722 | ||
| A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection | Q26252076 | ||
| Zika virus — reigniting the TORCH | Q26742229 | ||
| Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen | Q26747306 | ||
| In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine | Q27901935 | ||
| Mumps | Q28272753 | ||
| Evidence of Sexual Transmission of Zika Virus | Q28274810 | ||
| Direct immunologic activities of CpG DNA and implications for gene therapy | Q33876146 | ||
| Rapid development of a DNA vaccine for Zika virus | Q34542032 | ||
| A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates | Q36069589 | ||
| Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation | Q37605206 | ||
| Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus | Q38782718 | ||
| Zika Virus: Immunity and Vaccine Development | Q38969772 | ||
| Corrigendum: Zika viral dynamics and shedding in rhesus and cynomolgus macaques | Q40050023 | ||
| A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication | Q40051279 | ||
| Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice | Q40052371 | ||
| Zika virus infection damages the testes in mice | Q40053231 | ||
| Microhematospermia in acute Zika virus infection | Q42997551 | ||
| Zika virus in semen and spermatozoa. | Q42997899 | ||
| Zika vaccine candidates progress through nonclinical development and enter clinical trials | Q47168453 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Zika virus | Q202864 |
| Zika fever vaccine | Q24657950 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 15743 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | DNA vaccination protects mice against Zika virus-induced damage to the testes | |
| P478 | volume | 8 |
| Q91750540 | A Novel Cre Recombinase-Mediated In Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus |
| Q90705153 | A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue |
| Q89678906 | A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection |
| Q41689803 | A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage |
| Q51336011 | A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. |
| Q56341896 | An Update on Sexual Transmission of Zika Virus |
| Q57050781 | Assay Challenges for Emerging Infectious Diseases: The Zika Experience |
| Q54558551 | Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway. |
| Q47549528 | Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses |
| Q64257362 | Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine |
| Q94561515 | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections |
| Q55024075 | Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation. |
| Q38158576 | Current views on Zika virus vaccine development |
| Q91664048 | DNA vaccines: prime time is now |
| Q91711499 | Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade |
| Q50223468 | Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone |
| Q47315490 | Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. |
| Q91797383 | Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice |
| Q91576851 | Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development |
| Q94523117 | Evaluating Zika Virus Pathogenesis in Immunocompromised Mice |
| Q59245612 | Fast Tracks and Roadblocks for Zika Vaccines |
| Q47547869 | Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia Compared to a Canadian-Imported Thai Strain |
| Q91566784 | Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses |
| Q38158070 | Impact of Zika virus for infertility specialists: current literature, guidelines, and resources |
| Q63248475 | In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus |
| Q66679794 | Increased growth ability and pathogenicity of American- and Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast Asian-subtype ZIKV strain |
| Q56341985 | Infection of epididymal epithelial cells and leukocytes drives seminal shedding of Zika virus in a mouse model |
| Q92593502 | Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses |
| Q61442844 | Persistence and clinical relevance of Zika virus in the male genital tract |
| Q50120730 | Puzzling over privilege: How the immune system protects-and fails-the testes |
| Q51336164 | Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. |
| Q92689707 | Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy |
| Q56344087 | Sexual transmission of Zika virus and other flaviviruses: A living systematic review |
| Q91741475 | Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design |
| Q43046904 | Understanding the Pathogenesis of Zika Virus Infection Using Animal Models. |
| Q64263739 | Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice |
| Q92130293 | Zika Vaccine Development-Current Progress and Challenges for the Future |
| Q91730082 | Zika Vaccine Development: Current Status |
| Q54558333 | Zika Virus Trafficking and Interactions in the Human Male Reproductive Tract. |
| Q58742686 | Zika Virus Vaccines: Challenges and Perspectives |
| Q52586122 | Zika Virus in the Male Reproductive Tract. |
| Q94523111 | Zika Virus: A Brief History and Review of Its Pathogenesis Rediscovered |
| Q41918225 | Zika virus and reproduction: facts, questions and current management |
| Q38156575 | Zika virus infection in semen: effect on human reproduction |
| Q56342405 | Zika virus infects human testicular tissue and germ cells |
| Q56343708 | Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization |
Search more.